by Eric L. Young | Dec 19, 2018 | China, Customs Fraud, False Claims Act, Whistleblower
Domestic importers are paying record amounts in customs duties due to a recent surge in the number of new tariffs, according to a recent article in the Wall Street Journal. In October, American companies paid $6.2 billion in duties, including $2.8 billion in new...
by Eric L. Young | Dec 6, 2018 | False Claims Act, Fraud, Health Care, Information Technology, Medicaid, Medicare, Qui Tam, Whistleblower
The Wall Street Journal recently reported that the Department of Veterans Affairs is in discussions with Apple to provide portable electronic health records (“EHRs”) to military veterans. The plan reportedly calls for Apple to develop specialized software tools that...
by Eric L. Young | Nov 30, 2018 | False Claims Act, Fraud, Health Care, Qui Tam, Whistleblower
The opioid epidemic has exacted an immeasurable cost on our country in both human and financial costs. It has also given rise to a new type of health care scam in America – addiction treatment fraud. Unscrupulous operators of drug treatment centers and sober...
by Eric L. Young | Nov 21, 2018 | Health Care
In the past four years, pharmaceutical companies have more than doubled their ad spending, making it the second-fastest growing ad category in the nation. Other healthcare providers, from local hospitals to nationally known cancer treatment centers, are also...
by Eric L. Young | May 15, 2018 | DOJ, Investigations, News, Press Releases, Whistleblower
The United States Department of Justice and numerous state governments have intervened in numerous qui tam whistleblower suits, including one brought by Philadelphia based law firm Young Law Group against INSYS Therapeutics, Inc. [1]. The suit alleges, among other...
